JP2017521433A5 - - Google Patents

Download PDF

Info

Publication number
JP2017521433A5
JP2017521433A5 JP2017501004A JP2017501004A JP2017521433A5 JP 2017521433 A5 JP2017521433 A5 JP 2017521433A5 JP 2017501004 A JP2017501004 A JP 2017501004A JP 2017501004 A JP2017501004 A JP 2017501004A JP 2017521433 A5 JP2017521433 A5 JP 2017521433A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid polymer
pharmaceutically acceptable
use according
polymer further
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017501004A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017521433A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2015/050626 external-priority patent/WO2016004525A1/en
Publication of JP2017521433A publication Critical patent/JP2017521433A/ja
Publication of JP2017521433A5 publication Critical patent/JP2017521433A5/ja
Priority to JP2020074639A priority Critical patent/JP6922030B2/ja
Pending legal-status Critical Current

Links

JP2017501004A 2014-07-10 2015-07-07 Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法 Pending JP2017521433A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020074639A JP6922030B2 (ja) 2014-07-10 2020-04-20 Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462022846P 2014-07-10 2014-07-10
US62/022,846 2014-07-10
US201462091943P 2014-12-15 2014-12-15
US62/091,943 2014-12-15
PCT/CA2015/050626 WO2016004525A1 (en) 2014-07-10 2015-07-07 Methods for the treatment of hepatitis b and hepatitis d virus infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020074639A Division JP6922030B2 (ja) 2014-07-10 2020-04-20 Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法

Publications (2)

Publication Number Publication Date
JP2017521433A JP2017521433A (ja) 2017-08-03
JP2017521433A5 true JP2017521433A5 (enExample) 2018-08-16

Family

ID=55063440

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017501004A Pending JP2017521433A (ja) 2014-07-10 2015-07-07 Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法
JP2020074639A Expired - Fee Related JP6922030B2 (ja) 2014-07-10 2020-04-20 Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020074639A Expired - Fee Related JP6922030B2 (ja) 2014-07-10 2020-04-20 Ｂ型肝炎およびｄ型肝炎ウイルス感染の治療のための方法

Country Status (34)

Country Link
US (1) US9603865B2 (enExample)
EP (1) EP3166615B1 (enExample)
JP (2) JP2017521433A (enExample)
KR (2) KR20170029577A (enExample)
CN (2) CN113750112A (enExample)
AU (1) AU2015286199B2 (enExample)
BR (1) BR112017000320B1 (enExample)
CA (1) CA2954182C (enExample)
CL (1) CL2017000008A1 (enExample)
CU (1) CU20170001A7 (enExample)
CY (1) CY1126361T1 (enExample)
DK (1) DK3166615T3 (enExample)
DO (1) DOP2017000002A (enExample)
EA (1) EA036745B1 (enExample)
EC (1) ECSP16097355A (enExample)
ES (1) ES2963814T3 (enExample)
FI (1) FI3166615T3 (enExample)
HK (1) HK1231402A1 (enExample)
HR (1) HRP20231400T1 (enExample)
HU (1) HUE064449T2 (enExample)
IL (1) IL249660B (enExample)
LT (1) LT3166615T (enExample)
MD (1) MD4760C8 (enExample)
MX (1) MX381042B (enExample)
MY (1) MY178087A (enExample)
PH (1) PH12017500010B1 (enExample)
PL (1) PL3166615T3 (enExample)
PT (1) PT3166615T (enExample)
RS (1) RS64833B1 (enExample)
SG (1) SG11201700073PA (enExample)
SI (1) SI3166615T1 (enExample)
SM (1) SMT202300380T1 (enExample)
TW (1) TWI766831B (enExample)
WO (1) WO2016004525A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11166976B2 (en) 2018-11-08 2021-11-09 Aligos Therapeutics, Inc. S-antigen transport inhibiting oligonucleotide polymers and methods
US20200147124A1 (en) * 2018-11-08 2020-05-14 Aligos Therapeutics, Inc. S-antigen transport inhibiting oligonucleotide polymers and methods
WO2021119325A1 (en) * 2019-12-12 2021-06-17 Aligos Therapeutics, Inc. S-antigen transport inhibiting oligonucleotide polymers and methods
WO2021223398A1 (zh) * 2020-05-07 2021-11-11 西安新通药物研究股份有限公司 治疗肝病的晶型及其应用
CN113651853A (zh) * 2020-05-07 2021-11-16 西安新通药物研究股份有限公司 甲磺酸帕拉德福韦c晶型及其应用
CN114057816B (zh) * 2020-07-30 2025-02-11 浙江柏拉阿图医药科技有限公司 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用
WO2022109129A1 (en) * 2020-11-20 2022-05-27 Aligos Therapeutics, Inc. Conjugates of s-antigen transport inhibiting oligonucleotide polymers having enhanced liver targeting
TW202245809A (zh) 2020-12-18 2022-12-01 美商詹森藥物公司 用於治療b型肝炎病毒感染之組合療法
WO2022152869A1 (en) 2021-01-15 2022-07-21 Janssen Sciences Ireland Unlimited Company Use of oligonucleotides for individuals with hepatic impairment
WO2022261046A1 (en) * 2021-06-07 2022-12-15 Antios Therapeutics, Inc. Compositions and methods of treating hepatitis d and hepatitis b/hepatitis d co-infections with phosphoramidate clevudine prodrugs
CN117616121A (zh) 2021-07-09 2024-02-27 葛兰素史密斯克莱知识产权(第3号)有限公司 寡核苷酸用于具有肾脏损伤的个体的用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482836A (en) * 1993-01-14 1996-01-09 The Regents Of The University Of California DNA purification by triplex-affinity capture and affinity capture electrophoresis
EA008940B1 (ru) 2002-09-13 2007-10-26 Репликор, Инк. Антивирусные олигонуклеотиды, не связанные с комплементарностью последовательностей
US9474793B2 (en) * 2005-02-22 2016-10-25 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus
JP5775581B2 (ja) 2010-08-20 2015-09-09 レプリコール インコーポレーティッド オリゴヌクレオチドキレート錯体
WO2012058210A1 (en) * 2010-10-29 2012-05-03 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA)
WO2012075114A2 (en) * 2010-12-01 2012-06-07 Ablitech, Inc. Nucleic acid-polymer conjugates and uses thereof
AR091065A1 (es) * 2012-05-18 2014-12-30 Replicor Inc Una formulacion farmaceutica que comprende un quelato de oligonucleotidos antiviral para el tratamiento de una infeccion antiviral
HUE054875T2 (hu) * 2012-05-18 2021-10-28 Replicor Inc Oligonukleotid kelátkomplex-polipeptid készítmények és eljárások
CN104837501B (zh) * 2012-08-30 2018-11-02 里普利科股份有限公司 治疗乙型肝炎及丁型肝炎感染的方法

Similar Documents

Publication Publication Date Title
FI3166615T3 (fi) Kelatoituja fosforotioaattinukleiinihappopolymeerejä käytettäväksi yhdistelmänä HBV-polymeraasin inhibiittorin kanssa hepatiitti B- ja hepatiitti D -virusinfektioiden hoitamiseksi
MX2009012433A (es) Azido nucleosidos de purina para el tratamiento de infecciones virales.
JP2022532211A5 (enExample)
JP2016527217A5 (enExample)
JP2016508134A5 (enExample)
FI3837366T3 (fi) Hepatiitti b -viruksen (hbv) dsrna-ainekoostumuksia ja niiden käyttömenetelmiä
JP2013522302A5 (enExample)
ES2982897T3 (es) Uso del inhibidor de la telomerasa imetelstat para el tratamiento de trastornos mieloproliferativos y neoplasias mieloproliferativas
JP2016531144A5 (enExample)
JP2015504650A5 (enExample)
JP2018188483A5 (enExample)
WO2007070598A8 (en) Nucleotide and oligonucleotide prodrugs
JP2015038149A5 (enExample)
JP2016503800A5 (enExample)
JP2004513070A5 (enExample)
JP2013056886A5 (enExample)
JP2017513469A5 (enExample)
JP2015504438A5 (enExample)
JP2010503695A5 (enExample)
CA2389745A1 (en) Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues
RU2005133711A (ru) Антисмысловые олигонуклеотиды (odn) к smad7 и их применение в области медицины
JP2021090458A5 (enExample)
JP2005525991A5 (enExample)
TW201723178A (zh) 具拮抗ｐｄｌ１功能的適體分子於癌症治療之應用
WO2010068708A3 (en) 3'-azido purine nucleotide prodrugs for treatment of viral infections